Encode Ideas, L.P. Announces the Initiation of Research Coverage on Titan Medical, Inc.
Dover, Delaware--(Newsfile Corp. - October 28, 2021) - Encode Ideas, L.P. Initiates Research on Titan Medical, Inc. (NASDAQ: TMDI) (TSX: TMD). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P. is initiating coverage on Titan Medical, Inc. as a High Conviction Investment Idea. Titan is a medical device company headquartered in Toronto, Ontario with R&D facilities in Chapel Hill, North Carolina, and is focused on enhancing robotic-assisted surgery using...
2021-10-28 4:01 PM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on NervGen Pharma Corp.
Dover, Delaware--(Newsfile Corp. - September 13, 2021) - Encode Ideas, L.P. Initiates Research on NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF). The full research publication can be found on our website at www.encodelp.com, or by clicking here.Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF). NervGen Pharma Corp. is a clinical stage biotech company dedicated to discovering and developing treatments for patients suffering from medical conditions related...
2021-09-13 9:00 AM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Modular Medical, Inc.
Dover, Delaware--(Newsfile Corp. - June 7, 2021) - Encode Ideas, L.P. Initiates Research on Modular Medical, Inc. (OTCQB: MODD). The full research publication can be found on our website at www.encodelp.com.Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Modular Medical, Inc. (OTCQB: MODD). Modular Medical, Inc. (OTCQB: MODD) is a development-stage diabetes technology company based in San Diego, CA. Modular seeks to expand access to high end diabetes technologies to the heretofore neglected...
2021-06-07 9:00 AM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Processa Pharmaceuticals, Inc.
Dover, Delaware--(Newsfile Corp. - February 22, 2021) - Encode Ideas, L.P. Initiates Research on Processa Pharmaceuticals, Inc. (NASDAQ: PCSA). The full research publication is available here and available on our website at www.encodelp.com. Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Processa Pharmaceuticals, Inc. (NASDAQ: PCSA). The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options...
2021-02-22 8:30 AM EST
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Ocuphire Pharma Inc.
Dover, Delaware--(Newsfile Corp. - November 9, 2020) - Encode Ideas, L.P. Initiates Research on Ocuphire Pharma Inc. (NASDAQ: OCUP). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Ocuphire Pharma, Inc. (NASDAQ: OCUP). Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's lead...
2020-11-09 9:00 AM EST
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Perimeter Medical Imaging, AI
Dover, Delaware--(Newsfile Corp. - October 21, 2020) - Encode Ideas, L.P. Initiates Research on Perimeter Medical Imaging, AI (TSXV: PINK) (FSE: 4PC). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P. is initiating coverage on Perimeter Medical Imaging AI, Inc. as a High Conviction Investment Idea. Perimeter's Optical Tissue Imaging System, or OTIS, is an FDA 510(k) cleared optical coherence technology (OCT) that can rapidly image large tissue surfaces,...
2020-10-21 8:30 AM EDT
Encode Ideas, L.P. to Host Key Opinion Leader Conference Call with Dr. Jonathan Zager, Principal Investigator for Delcath System's Phase 3 FOCUS Study
Dover, Delaware--(Newsfile Corp. - September 28, 2020) - Encode Ideas, L.P. announces they will be hosting a conference call with Dr. Jonathan Zager, surgical oncologist at Moffitt Cancer Center and the principal investigator for the Phase 3 FOCUS study, on Wednesday, September 30 at 3:00 pm Eastern Time. The purpose of the call will be to discuss the current metastatic ocular melanoma (mOM) treatment landscape, with a focus on the potential role that melphalan/hepatic delivery system via percutaneous hepatic...
2020-09-28 10:50 AM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Epigenomics AG.
Dover, Delaware--(Newsfile Corp. - June 17, 2020) - Encode Ideas, L.P. Initiates Research on Epigenomics AG (Xetra: ECX.DE) (FSE: ECX) (OTC: EPGNF). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Epigenomics AG as a High Conviction Investment Idea. Epigenomics has the first and only FDA-approved blood-based test, Epi proColon, for the detection of colorectal cancer. The company...
2020-06-17 3:00 AM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Delcath Systems, Inc.
Dover, Delaware--(Newsfile Corp. - May 19, 2020) - Encode Ideas, L.P. Initiates Research on Delcath Systems, Inc (NASDAQ: DCTH). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas is initiating coverage on Delcath Systems (NASDAQ: DCTH) as a high conviction investment idea. Delcath is an interventional oncology company developing a liver isolating technology, known as Hepatic Delivery System (HDS), that allows for high-dose chemotherapy, to be targeted towards tumors...
2020-05-19 8:30 AM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on TLC
Dover, Delaware--(Newsfile Corp. - April 27, 2020) - Encode Ideas, L.P. Initiates Research on TLC (NASDAQ: TLC) (TWO: 4152). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on TLC (NASDAQ: TLC) (TWO: 4152) as a high conviction idea. TLC is a leading drug delivery/reformulation company with two late-stage assets focused on pain, and earlier stage assets for oncology...
2020-04-27 8:30 AM EDT
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc.
Dover, Delaware--(Newsfile Corp. - November 25, 2019) - Encode Ideas, L.P. Initiates Research on Acasti Pharma, Inc. (NASDAQ: ACST). The full research publication is available here and available on our website at www.encodelp.com. Encode Ideas is initiating coverage on Acasti Pharma, Inc. as a high-risk investment idea. Acasti is developing a krill-based omega-3 fatty acid product, CaPre, for the treatment of severe hypertriglyceridemia. Acasti is currently conducting two virtually identical Ph3 studies - Trilogy I and Trilogy II- with...
2019-11-25 8:30 AM EST
Encode Ideas, L.P. Announces the Initiation of Research Coverage on ESSA Pharma, Inc.
Dover, Delaware--(Newsfile Corp. - November 11, 2019) - Encode Ideas, L.P. Initiates Research on ESSA Pharma, Inc. (NASDAQ: EPIX). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on ESSA Pharma, Inc, (NASDAQ: EPIX) as a high conviction investment idea. ESSA is developing a new class of prostate cancer drugs, known as anitens, which target a novel binding...
2019-11-11 9:00 AM EST
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Xenon Pharmaceuticals Inc.
Dover, Delaware--(Newsfile Corp. - October 16, 2019) - Encode Ideas, L.P. Initiates Research on Xenon Pharmaceuticals Inc. (NASDAQ: XENE). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Xenon Pharmaceuticals (NASDAQ: XENE) as a high conviction idea. Xenon is at the forefront of a new wave of precision medicine in neurology, with arguably the deepest and most advanced...
2019-10-16 8:30 AM EDT